Large Study Reveals Widespread Underdiagnosis and Poor Control of Hypertension in England

Researchers examining blood pressure data from over 100,000 participants in England's Our Future Health program found that 59% of people with hypertension had never been diagnosed or treated, while roughly half of those already taking medications still had elevated readings. The study reveals that hypertension remains a largely undetected and poorly managed condition despite being a major risk factor for heart attacks, strokes, and premature death. Experts highlight the need for more proactive screening and better medication management to prevent cardiovascular disease across the population.

The Oxford Population Health research team analyzed clinical blood pressure measurements from participants enrolled in Our Future Health between 2022 and 2025, applying standardized WHO diagnostic thresholds. The study's scope—over 100,000 individuals—provides substantial evidence about hypertension prevalence across England's adult population. Age emerged as a critical factor, with rates climbing from 15% in younger adults to 71% among those aged 80 and over, while sex-based differences also proved significant, with men experiencing notably higher prevalence than women.

The medication paradox revealed in the data suggests a treatment efficacy problem distinct from diagnostic challenges. Half of participants already receiving antihypertensive drugs continued experiencing elevated readings, indicating either inadequate dosing, poor medication adherence, or insufficient medication adjustment by clinicians. Researchers attribute current detection gaps partly to existing NHS guidance protocols that emphasize multiple confirmatory measurements and lifestyle interventions before pharmaceutical intervention.